These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6260499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL.
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J, van Steijn AM, Gelsema WJ, de Ligny CL.
    Int J Nucl Med Biol; 1986 Oct; 12(6):411-7. PubMed ID: 3011692
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.
    Ecclestone M, Proulx A, Ballinger JR, Gerson B, Reid RH, Gulenchyn KY.
    Eur J Nucl Med; 1990 Oct; 16(4-6):299-302. PubMed ID: 2161770
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Bone scintigraphy with 99mTc-pyrophosphate in the diagnosis of the degree of the spread of the tumor process in the head and neck area].
    Prikhod'ko AG.
    Med Radiol (Mosk); 1982 Jan; 27(1):58-67. PubMed ID: 6276643
    [No Abstract] [Full Text] [Related]

  • 14. Investigation of the parameters related to the formation of 99mTc-pyrophosphate complexes using gel chromatography column scanning.
    Shafiq YF, Al-Janabi MA, Al-Azzawi HM, Abdel-Azeez MA, Al-Hissoni MH, Jassim MN.
    Nuklearmedizin; 1985 Jun; 24(3):146-9. PubMed ID: 2997754
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD.
    J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
    [Abstract] [Full Text] [Related]

  • 17. Decomposition of Tc-99m pyrophosphate by peroxides in pertechnetate used in preparation.
    Der M, Ballinger JR, Bowen BM.
    J Nucl Med; 1981 Jul; 22(7):645-6. PubMed ID: 6265608
    [Abstract] [Full Text] [Related]

  • 18. Effects of renal failure and metabolic diseases upon bone scanning in children.
    Schümichen C.
    Ann Radiol (Paris); 1983 Jul; 26(6):498-504. PubMed ID: 6316830
    [No Abstract] [Full Text] [Related]

  • 19. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
    Weber DA, Makler PT, Watson EE, Coffey JL, Thomas SR, London J.
    J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
    [No Abstract] [Full Text] [Related]

  • 20. Predictive value of 99mTc pyrophosphate bone scintigraphy for vitamin D trials in uraemia.
    Vanherweghem JL, Dhaene M, Tielemans C, Dratwa M, Verbanck P, Bergmann P, Schoutens A, Fuss M.
    Proc Eur Dial Transplant Assoc; 1981 Jun; 18():648-51. PubMed ID: 6276883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.